These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Tumor lysis syndrome in children with non-Hodgkin lymphoma. Alavi S; Arzanian MT; Abbasian MR; Ashena Z Pediatr Hematol Oncol; 2006; 23(1):65-70. PubMed ID: 16326415 [TBL] [Abstract][Full Text] [Related]
8. Tumor lysis syndrome and acute kidney injury: evaluation, prevention, and management. Abu-Alfa AK; Younes A Am J Kidney Dis; 2010 May; 55(5 Suppl 3):S1-13; quiz S14-9. PubMed ID: 20420966 [TBL] [Abstract][Full Text] [Related]
9. Acute tumour lysis syndrome and the kidney. Lameire N Neth J Med; 1994 Nov; 45(5):193-7. PubMed ID: 7830844 [No Abstract] [Full Text] [Related]
10. Tumor lysis syndrome in the era of novel and targeted agents in patients with hematologic malignancies: a systematic review. Howard SC; Trifilio S; Gregory TK; Baxter N; McBride A Ann Hematol; 2016 Mar; 95(4):563-73. PubMed ID: 26758269 [TBL] [Abstract][Full Text] [Related]
11. Tyrosine kinase inhibitors and tumor lysis syndrome in hematologic malignancies: A systemic review. Salter B; Burns I; Fuller K; Eshaghpour A; Lionel AC; Crowther M Eur J Haematol; 2022 Aug; 109(2):166-181. PubMed ID: 35531791 [TBL] [Abstract][Full Text] [Related]
12. [Pseudoleukocytosis and pseudothrombocytosis caused by fragmentation of leukemic cells in tumor lysis syndrome]. Hagino T; Kaito K; Asai O; Dobashi N; Yano S; Takei Y; Sugiyama K; Saito T; Okawa Y; Aiba K; Usui N Rinsho Ketsueki; 2007 Dec; 48(12):1559-62. PubMed ID: 18203517 [TBL] [Abstract][Full Text] [Related]
14. Management of tumor lysis syndrome in patients with multiple myeloma during bortezomib treatment. Wang L; Jian Y; Yang G; Gao W; Wu Y; Zuo L Clin J Oncol Nurs; 2015 Feb; 19(1):E4-7. PubMed ID: 25689664 [TBL] [Abstract][Full Text] [Related]
15. Tumor lysis syndrome after transcatheter arterial infusion of cisplatin and embolization therapy for liver metastases of melanoma. Nakamura Y; Nakamura Y; Hori E; Furuta J; Ishii Y; Takahashi T; Kawachi Y; Otsuka F Int J Dermatol; 2009 Jul; 48(7):763-7. PubMed ID: 19570088 [TBL] [Abstract][Full Text] [Related]
16. [Guideline for management of tumor lysis syndrome]. Comité Nacional de Hematología Arch Argent Pediatr; 2011 Feb; 109(1):77-82. PubMed ID: 21283951 [TBL] [Abstract][Full Text] [Related]
17. The management of tumor lysis syndrome. Rampello E; Fricia T; Malaguarnera M Nat Clin Pract Oncol; 2006 Aug; 3(8):438-47. PubMed ID: 16894389 [TBL] [Abstract][Full Text] [Related]
18. Tumor lysis syndrome: prevention and detection to enhance patient safety. Maloney K; Denno M Clin J Oncol Nurs; 2011 Dec; 15(6):601-3. PubMed ID: 22119971 [TBL] [Abstract][Full Text] [Related]
19. Catastrophic tumour lysis syndrome following single dose of imatinib. Keane C; Henden A; Bird R Eur J Haematol; 2009 Mar; 82(3):244-5. PubMed ID: 19067739 [No Abstract] [Full Text] [Related]
20. The role of hypercytokinemia in the pathophysiology of tumor lysis syndrome (TLS) and the treatment with continuous hemodiafiltration using a polymethylmethacrylate membrane hemofilter (PMMA-CHDF). Nakamura M; Oda S; Sadahiro T; Hirayama Y; Tateishi Y; Abe R; Hirasawa H Transfus Apher Sci; 2009 Feb; 40(1):41-7. PubMed ID: 19109071 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]